Cytokeratin 10 and Cytokeratin 19: Predictive Markers for Poor Prognosis in Hepatocellular Carcinoma Patients after Curative Resection
Open Access
- 15 June 2008
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 14 (12), 3850-3859
- https://doi.org/10.1158/1078-0432.ccr-07-4338
Abstract
Purpose: Cytokeratin 10 (CK10) was found to be expressed differently in human hepatocellular carcinoma (HCC) cell lines with different metastatic potentials in our previous research. The aim of this study was to assess the value of CK10 alone or in combination with cytokeratin 19 (CK19) in predicting tumor recurrence after curative resection in HCC patients. Experimental Design: CK10 expression in stepwise metastatic HCC cell lines and tumor tissues from 50 HCC patients was investigated using immunofluorescence assay, quantitative real-time reverse transcription-PCR, and Western blot analyses. Tumor tissue microarrays of 300 HCC patients who underwent curative resection between 1997 and 2000 were used to detect the expressions of CK10 and CK19. Clinicopathologic data for these patients were evaluated. The prognostic significance was assessed using Kaplan-Meier survival estimates and log-rank tests. Results: CK10 was overexpressed in the high metastatic HCC cell line and in tumor tissues of recurrent patients. Both univariate and multivariate analyses revealed that CK10 was a significant predictor for overall survival (OS) and disease-free survival, and that CK19 was a significant predictor for OS. CK10 expression was correlated with poor prognosis regardless of α-fetoprotein, tumor-node-metastasis stage, and vascular invasion. The 7-year OS and disease-free survival rates in CK10+ and/or CK19+ patients were 30.0% and 37.6%, respectively, which were significantly lower than that of CK10−/CK19− patients (56.1% and 60.0%, respectively; P < 0.001). Conclusion: CK10 is associated with HCC invasiveness. CK10 alone, or in combination with CK19, can be a novel predictor for poor prognosis of HCC patients after curative resection.Keywords
This publication has 46 references indexed in Scilit:
- Hepatocellular Carcinoma: Epidemiology and Molecular CarcinogenesisGastroenterology, 2007
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Prognostic Value of Cytokeratin-Positive Bone Marrow Cells of Gastric Cancer PatientsAnnals of Surgical Oncology, 2006
- Dendritic cell infiltration and prognosis of human hepatocellular carcinomaZeitschrift für Krebsforschung und Klinische Onkologie, 2006
- Histological types and significance of bronchial epithelial dysplasiaLaboratory Investigation, 2006
- Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literatureZeitschrift für Krebsforschung und Klinische Onkologie, 2004
- High α‐fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: Significance of hepatitis virus infection, age, p53 and β‐catenin mutationsInternational Journal of Cancer, 2004
- Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristicsZeitschrift für Krebsforschung und Klinische Onkologie, 2004
- A decade?s studies on metastasis of hepatocellular carcinomaZeitschrift für Krebsforschung und Klinische Onkologie, 2003
- Expression of fetal cytokeratins in epidermai cells and colloid bodies in lichen planusJournal of Cutaneous Pathology, 1998